<p>KARACHI: Despite being registered by Pakistan’s drug regulator, around 40 new life-saving medicines remain unavailable to patients because the federal government has yet to approve their prices, forcing thousands of people suffering from cancer, diabetes, haemophilia, Parkinson’s disease and other serious illnesses to rely on expensive smuggled or unregistered medicines, officials and market sources said on Sunday.</p>
<p>The delayed price notifications, they said, have stalled the legal